CompletedPhase 4

A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of ICE Implant

Israel35 participantsStarted 2015-01

Plain-language summary

The current prospective clinical study's aim is to determine ABT's ICE implant survival rate, crestal interproximal bone resorption during 24 months post implant insertion and to assimilate the drilling sequence during the clinical use of ICE implants.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Men and women over the age of 18 years who need implantation of 1-4 implants.
✓. Patients who are able to understand the requirements of the study, and are willing and able to comply with its instructions and schedules.
✓. Patients who had provided written informed consent to participate in the study prior to any study procedure.
✓. Patients in general good health in the opinion of the principal investigator as determined by medical history and oral examination.

Exclusion criteria

✕. Immediate loaded implants.
✕. Treatment with anticoagulant drugs (INR under 1.8) or bisphosphonates.
✕. Treatment with anticonvulsants drugs.
✕. Untreated Periodontal disease and inability of the patient to maintain reasonable oral hygiene according to study requirements.
✕. Patients with history of alcohol, narcotics or drug abuse.
✕. Patients under steroid therapy.
✕. Patients receiving radiotherapy, chemotherapy or any other immunosuppressive treatment or who have been administered radiotherapy in the last 5 years.
✕. Metabolic bone disorders and/or bone augmentation.

What they're measuring

Cumulative Survival Rate

Timeframe: 24 MONTHS

Trial details

NCT IDNCT01960361

SponsorAlpha - Bio Tec Ltd.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2019-03

View on ClinicalTrials.gov More Implant Clinical Survival trials